Consensus statement on the use of clozapine during the COVID-19 pandemic

A consensus statement on the use of Clozapine during the COVID-19 outbreak developed by an expert advisory subgroup of the Treatment Response and Resistance in Psychosis working group may ​help providers and pharmacists understand the benefits and risks of reduced ANC blood monitoring during the current pandemic. Read the statement.

Page last modified: April 7, 2020